Clinical Trial Update: Study of Oral PCLX-001 in R/R Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating oral PCLX-001 for relapsed or refractory acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• PCLX-001

Snippet

Sponsor: Pacylex Pharmaceuticals | Conditions: Relapsed Adult AML | Phase 1 | Status: RECRUITING